Published in Blood Weekly, April 14th, 1997
The data was released at the 23rd Annual European Blood and Marrow Transplantation (EBMT) meeting. The authorization was granted through the European Mutual Recognition Procedure, a regulatory process designed and intended to speed up the review of a new drug that has been already approved in one EU country.
It was granted on the basis of several studies using Granocyte for PBPC mobilization. Granocyte...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.